Skip to Main Content

Paper Details

Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.
Br J Haematol
5
2020
HDAC, HL, HL and TCL cells lines, HL cells, Hodgkin (HL) lymphoma, Hodgkin and T-cell lymphoma, Ixazomib, Jurkat, Jurkat cells, L428 cells, NFE2L2, NRF2, T, T cell (TCL) and Hodgkin (HL, TCL, belinostat, histone deacetylase, ixazomib, ixazomib-sensitive and -resistant cell lines, primary cells, primary tumour, primary tumour cells, proteasomal gene, proteasome gene, resistant clones, treated cells, untreated control cells
Author NameAffiliation
John Tyson McDonaldCancer Research Center, Hampton University
Afshin BeheshtiNASA Ames Research Center
Andrew M EvensRutgers Cancer Institute of New Jersey
  • 1 - 3

Datasets

Release 1.2